HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew D Abell Selected Research

3-dehydroquinate dehydratase

9/2004Inhibitors of types I and II dehydroquinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew D Abell Research Topics

Disease

8Neoplasms (Cancer)
10/2021 - 02/2013
5Cataract (Cataracts)
01/2013 - 11/2005
3Breast Neoplasms (Breast Cancer)
10/2021 - 12/2016
1Tuberculosis (Tuberculoses)
11/2021
1Alzheimer Disease (Alzheimer's Disease)
12/2020
1Hypoxia (Hypoxemia)
01/2020
1Carcinoma (Carcinomatosis)
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2017
1Burns
03/2016
1Wounds and Injuries (Trauma)
03/2016
1Overnutrition
01/2016
1Male Infertility (Male Sterility)
04/2015
1Sarcoma (Soft Tissue Sarcoma)
02/2013
1Rubella (German Measles)
06/2011
1Hyperalgesia
08/2010
1Neuralgia (Stump Neuralgia)
08/2010
1Tics (Tic)
03/2010
1Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
01/2010
1Pain (Aches)
01/2008
1Traumatic Brain Injuries (Traumatic Brain Injury)
11/2005
1Necrosis
11/2005
1Dehydration (Water Stress)
09/2004

Drug/Important Bio-Agent (IBA)

6Peptides (Polypeptides)IBA
10/2021 - 01/2009
4Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2021 - 08/2018
4Pharmaceutical PreparationsIBA
10/2021 - 11/2005
3Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2016
3Proteasome InhibitorsIBA
01/2019 - 02/2013
3Opioid Analgesics (Opioids)IBA
06/2011 - 01/2008
3CalpainIBA
01/2009 - 11/2005
2EnzymesIBA
11/2021 - 09/2004
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019 - 12/2016
2Bortezomib (Velcade)FDA Link
12/2016 - 02/2013
2calpain inhibitorsIBA
01/2013 - 12/2008
2Ointments (Pastes)IBA
01/2013 - 12/2008
2LigandsIBA
03/2010 - 01/2008
1Biotin (Vitamin H)FDA Link
11/2021
1desthiobiotin (dethiobiotin)IBA
11/2021
1Amyloid beta-PeptidesIBA
12/2020
1ProdrugsIBA
01/2020
1CationsIBA
01/2019
1Cyclic Nucleotide-Gated Cation ChannelsIBA
01/2019
1LithiumIBA
01/2019
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2017
1ThiazolidinedionesIBA
01/2017
1carfilzomibIBA
12/2016
1ChymotrypsinFDA Link
12/2016
1AlkaliesIBA
03/2016
1Nonesterified Fatty Acids (NEFA)IBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2015
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
02/2013
1ATP dependent 26S protease (26S proteasome)IBA
02/2013
1KynurenineIBA
06/2011
1Amino AcidsFDA Link
08/2010
1Glutamate Receptors (Glutamate Receptor)IBA
08/2010
11,2,3,4-tetrahydroisoquinolineIBA
03/2010
1Guanosine 5'-O-(3-Thiotriphosphate)IBA
03/2010
1GoldIBA
01/2010
1Thioctic Acid (Lipoic Acid)IBA
01/2010
1macrocycle 1IBA
01/2009
1CalciumIBA
01/2009
1Ophthalmic Solutions (Eye Drops)IBA
12/2008
15-formyl-pyrrole-2-carboxylic acid (1- (1- formyl- 3- methyl- butylcarbamoyl)- 2- methyl- propyl)amideIBA
12/2008
1Cysteine Proteases (Cysteine Protease)IBA
11/2005
13-dehydroquinate dehydrataseIBA
09/2004
1Quinic Acid (Quinate)IBA
09/2004
1shikimateIBA
09/2004

Therapy/Procedure

4Therapeutics
11/2021 - 12/2016
1Slit Lamp
12/2008